Cart
sales@molnova.com
Cilostamide
CAS No. 68550-75-4
Cilostamide( OPC3689 )
Catalog No. M20984 CAS No. 68550-75-4
Cilostamide is a selective phosphodiesterase (PDE)3A and PDE3B inhibitor(IC50 values of 27 and 50 nM respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 59 | In Stock |
|
| 2MG | 33 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 86 | In Stock |
|
| 25MG | 174 | In Stock |
|
| 50MG | 258 | In Stock |
|
| 100MG | 387 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCilostamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionCilostamide is a selective phosphodiesterase (PDE)3A and PDE3B inhibitor(IC50 values of 27 and 50 nM respectively).
-
DescriptionCilostamide is a selective phosphodiesterase (PDE)3A and PDE3B inhibitor(IC50 values of 27 and 50 nM respectively).
-
In Vitro——
-
In Vivo——
-
SynonymsOPC3689
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number68550-75-4
-
Formula Weight342.43
-
Molecular FormulaC20H26N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:31 mg/mL (90.53 mM)
-
SMILESCN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1
-
Chemical NameN-Cyclohexyl-N-methyl-4-(12-dihydro-2-oxo-6-quinolyloxy)butyramide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cilostamide affects in a concentration and exposure time-dependent manner the viability and the kinetics of in vitro maturation of caprine and bovine oocytes.[J]. Research in veterinary science 2018.
molnova catalog
related products
-
PF‐04447943
A potent, selective, brain penetrant, orally active PDE9A inhibitor with IC50 of 8.3 nM.
-
Heptaminol hydrochlo...
Heptaminol hydrochloride is a vasoconstrictor, used in the treatment of low blood pressure, particularly orthostatic hypotension.
-
UK-369003
UK-369003 (Gisadenafil besylate) is a novel, potent, selective, orally bioavailable PDE5 inhibitor with IC50 of 1.23 nM.
